RecruitingNCT04670172

Real-Life Chronic Rhinosinusitis Outcome Registry


Sponsor

Change Accelerator in Respiratory Care

Enrollment

4,550 participants

Start Date

Jan 1, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

An international consortium of leading medical experts in the field of chronic respiratory disease, the research team of Galenus Health and the non-profit organization EUFOREA (European Forum for Research and Education in Allergy and Airway diseases) has been conceived to conduct real-life outcome research. The Galenus Health digital platform consisting of a mobile application for patients and an online dashboard for physicians will be implemented in each of the participating centres. The data will be centralized in a pseudonymized database and will be the basis of the Chronic RhinoSinusitis Outcome Registry.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Physician diagnosis of Chronic RhinoSinusitis
  • Capable of using a mobile application on a smartphone

Exclusion Criteria3

  • Patients with malignancies of the sinonasal cavity
  • Patients with inverted papilloma
  • Patients with unilateral disease

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(13)

Graz University Hospital

Graz, Austria

University Hospital Vienna

Vienna, Austria

UCL Saint-Luc

Brussels, Belgium

UZ Ghent

Ghent, Belgium

UZ Leuven

Leuven, Belgium

Odense University Hospital

Odense, Denmark

Helsinki University Hospital

Helsinki, Finland

CHU Lille

Lille, France

Dusseldorf University Clinic

Düsseldorf, Germany

Policlinico Umberto I

Rome, Italy

UMC Amsterdam

Amsterdam, Netherlands

Hospital Clinic de Barcelona

Barcelona, Spain

Prof Claire Hopkins private practice

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04670172


Related Trials